BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8585721)

  • 1. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
    Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures.
    Mazumder A; Neamati N; Ojwang JO; Sunder S; Rando RF; Pommier Y
    Biochemistry; 1996 Oct; 35(43):13762-71. PubMed ID: 8901518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine.
    Ojwang J; Elbaggari A; Marshall HB; Jayaraman K; McGrath MS; Rando RF
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):560-70. PubMed ID: 7513761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
    Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
    Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
    Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystamine inhibits human immunodeficiency virus-1 replication in cord blood-derived mononuclear phagocytes and lymphocytes.
    Ho WZ; Kaufman D; Song L; Cutillii JR; Douglas SD
    Blood; 1996 Aug; 88(3):928-33. PubMed ID: 8704251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
    Dueweke TJ; Poppe SM; Romero DL; Swaney SM; So AG; Downey KM; Althaus IW; Reusser F; Busso M; Resnick L
    Antimicrob Agents Chemother; 1993 May; 37(5):1127-31. PubMed ID: 7685995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
    Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
    Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
    Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
    Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
    Wiskerchen M; Muesing MA
    J Virol; 1995 Jan; 69(1):376-86. PubMed ID: 7983732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction.
    Bader JP; McMahon JB; Schultz RJ; Narayanan VL; Pierce JB; Harrison WA; Weislow OS; Midelfort CF; Stinson SF; Boyd MR
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6740-4. PubMed ID: 1713689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs.
    Suzuki J; Miyano-Kurosaki N; Kuwasaki T; Takeuchi H; Kawai G; Takaku H
    J Virol; 2002 Mar; 76(6):3015-22. PubMed ID: 11861867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion selective folding of loop domains in a potent anti-HIV oligonucleotide.
    Jing N; Rando RF; Pommier Y; Hogan ME
    Biochemistry; 1997 Oct; 36(41):12498-505. PubMed ID: 9376354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
    Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
    J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide.
    Bishop JS; Guy-Caffey JK; Ojwang JO; Smith SR; Hogan ME; Cossum PA; Rando RF; Chaudhary N
    J Biol Chem; 1996 Mar; 271(10):5698-703. PubMed ID: 8621435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads.
    Rando RF; Ojwang J; Elbaggari A; Reyes GR; Tinder R; McGrath MS; Hogan ME
    J Biol Chem; 1995 Jan; 270(4):1754-60. PubMed ID: 7829511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
    Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
    J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.